Clinical Trial Update: Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing uninterrupted dabigatran etexilate to uninterrupted warfarin during pulmonary vein ablation in atrial fibrillation has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2017-11-14